Default company panoramic image
1541ae13 dc84 4bed 8420 510ef4633ecb

QuRetino Therapeutics Inc.

QuRetino is aiming to bring the next generation of acne vulgaris treatment with a highly selective more efficacious and safer topical drug

  • Stage Product In Development
  • Industry Biotechnology
  • Location Palo Alto, CA, USA
  • Currency USD
  • Founded October 2012
  • Employees 2

Company Summary

The mission of QuRetino is to successfully identify, rapidly develop, and bring to market with high sale potential new pharmaceutical products in specialized disease areas like Acne Vulgaris, by adding clinical POC. Our exit strategy is partnering, licensing or purchase by another company for further development to market.


  • Default avatar
    Marie Jhin

    20 years working as a Board Certified dermatologist as well as 10 years Adjunct Clinical Instructor at Stanford University. Owner of Premier Dermatology in San Carlos and San Francisco. Published author and entrepreneur also current investor in the company.

  • Default avatar
    Ferenc Makra
    Founder/President & CSO

    Proven 26 years of experience in the pharmaceutical industry (Syva, Syntex and Roche) as a drug discovery scientist, research strategist, manager and inventor. Entrepreneur skilled at recognizing promising business opportunities in life science. Able to transform an idea into a concrete development strategy and company. Current investor in the company.

  • Default avatar
    Roger Whiting
    Board of Directors

    Over 40 years of experience as a scientist, inventor and entrepreneur. Formally SVP at Syntex, Roche, co-Founder of RoxRo Pharma, CEO and President at Altos Therapeutics

  • Default avatar
    Howard I Maibach
    SAB member

    50 years of experience in dermatology, 40 years professor at UCSF, member of editorial board of more than 30 scientific journals, member of American Academy of Dermatology, published 1700 articles and textbooks

  • Default avatar
    Macus A. Conant MD.
    Clinical Development

    Over 40 years experience as a dermatologist and professor of UCSF, founder of several HIV clinics, formerly CMO of Presido Pharmaceutical & fm-SALUS Pharmaceutical

  • Default avatar
    Vern Norviel
    corporate lawyer &legal counsel

    WSG&R partner, adjunct professor at UC Berkley, Advisory Board Member of Center for Science Technology, Board Member of Parkinson Institute


  • Default avatar
    Vern Norviel at Wilson Sonsini
    Default avatar
    Tony H. Tarabay, CPA

Previous Investors

  • Default avatar
    Ferenc Makra (Founder)
    Default avatar
    Dr. Marie Jhin (CMO)
    Default avatar
    Ms. Ilona Merli (friend)